Bioprinting bone with genes for growth factors improves bone repair

Researchers at Penn State are bioprinting bone with encoding genes that enhance healing and regeneration. The researchers successfully used the technique on rat skulls.

Engineers use bioprinting during bone reconstruction surgery to heal and strengthen skull defects. Photo: Charles William Andrews

"Growth factors are essential for cell growth," said engineer Ibrahim Ozbolat, corresponding author of the study.

"We use two different genes encoding two different growth factors. These growth factors help stem cells to migrate into the defect area and then help the progenitor cells to convert into bone."

The team combined a platelet-derived growth factor and a protein that improves regeneration via bioprinting and used a controlled co-delivery release.

The encoding genes the team developed were printed to rat skulls during surgery and resulted in more bone creation and coverage.

"This method is better than simply dumping the growth factors," said Ozbolat.

"If we do that, the amounts of proteins are finite, but if we use gene therapy, the cells continue to produce the necessary growth factors." (National Science Foundation)

YOU MAY ALSO LIKE

‘Stressed’ cells offer clues to eliminating build-up of toxic proteins in dementia

It’s often said that a little stress can be good for you. Now scientists have shown that the same may be true for cells, uncovering a newly-discovered mechanism that might help prevent the build-up of tangles of proteins commonly seen in dementia.

Structures considered key to gene expression are surprisingly fleeting

Theories of how loops control gene expression may need to be revised.

Nanomaterial could enhance diabetes treatment

Advance in technology manages glucose and protects cognitive function.

Unique binding of Delta variant may explain high transmissibility

NIH findings could lead to ways to combat future SARS-CoV-2 variants.

Researchers engineer a new way to model lymph system conditions

Organ-on-a-chip model could result in new treatment options.

Study finds mutated protein structure at the root of blood cancers

Structural findings could result in more effective, less toxic treatments.